From: Feline leishmaniosis with focus on ocular manifestation: a case report
Day | Leishmania qPCRA (/ml blood) | Leishmania spp. IFATB ≤ 1:32 negative | Serum amyloid AC < 6.7 µg/l | HematologyD | Treatment |
---|---|---|---|---|---|
0 | 768 | 1:4096 | 77.5 | Mild reticulocytosis; mild leukocytosis with lymphocytosis, monocytosis and eosinopenia; mild thrombocytopenia | Allopurinol 12.5 mg BID p.o.1 Meloxicam 0.05 mg/kg SID p.o.2 |
48 | 191 | 1:512 | 35.2 | Mild non-regenerative anemia; mild leukocytosis with monocytosis | Allopurinol 12.5 mg BID p.o.1 Meloxicam 0.05 mg/kg SID p.o.2 |
66 | 1 | 1:1024 | 21.4 | Mild regenerative anemia | Allopurinol 12.5 mg BID p.o.1 Meloxicam 0.05 mg/kg SID p.o.2 |
75 | – | – | – | – | Allopurinol 12.5 mg BID p.o.1 Meloxicam 0.05 mg/kg SID p.o.2 Prednisolone acetate3 after healing of the corneal erosion) and Ketorolac-Trometamol4 1 drop BID in each eye |
96 | 238 | 1:1024 | 15.2 | Mild regenerative anemia; mild leukocytosis with lymphocytosis and monocytosis | Allopurinol 25 mg BID p.o.1 Meloxicam 0.05 mg/kg SID p.o.2 Prednisolone acetate3, Ketorolac-Trometamol4 and Nepafenac5 1 drop BID in each eye |
117 | 94 | 1:512 | 13.6 | – | Allopurinol 25 mg BID p.o.1 Meloxicam 0.05 mg/kg SID p.o.2 |
133 | – | 1:256 | – | Mild leukocytosis with monocytosis and eosinopenia | Allopurinol 25 mg BID p.o.1 Meloxicam 0.05 mg/kg SID p.o.2 Ophthalmological treatment protocolE |
196 | 11 | 1:256 | 5.9 | Mild non-regenerative anemia, mild monocytosis | Allopurinol 25 mg BID p.o.1 Meloxicam 0.05 mg/kg SID p.o.2 Ophthalmological treatment protocolE |
288 | 49 | 1:256 | 12.0 | Mild leukocytosis with monocytosis and eosinopenia | Allopurinol 25 mg BID p.o.1 Meloxicam 0.05 mg/kg SID p.o.2 Enucleation due to uveitis, glaucoma, and blindness |